The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 26th 2024
Amgen’s MariTide achieved up to 20% average weight loss at 52 weeks without hitting a plateau in individuals with obesity or overweight.
November 16th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Young Adults at Greatest Risk of Becoming Overweight, Developing Obesity
September 9th 2021An analysis of EHR data from more than 2 million patients in England is detailing the increased risk of becoming overweight or developing obesity in the next decade among young adults aged 18-24 compared to adults in other age groups.
Gender-Affirming Hormone Therapy Associated with Changes in Body Weight
August 26th 2021Hailed by investigators as the largest and longest study of its kind, new research is providing clinicians with an overview of the potential for weight change and obesity among patients receiving gender-affirming hormone therapy.
Rates of Gestational Diabetes on the Rise Among First-Time Mothers in the US
August 17th 2021A recent study published in JAMA details increasing rates of gestational diabetes among first-time mothers in the US from 2011-2019, with rates increasing across all racial/ethnic subgroups examined in the 12 million person analysis.
COVID-19, Lockdowns Have Slowed Weight Loss Following Bariatric Surgery
August 12th 2021An analysis of patients from a hospital in Belgium provides insight into the impact of COVID-19 and lockdowns on weight loss and overall health on patients who underwent gastric bypass and were impacted by COVID-19 during their first postoperative year.